Crossmark

Facilitators and barriers to participation of patients with treatment resistant depression in a randomised controlled trial of two forms of personalised magnetic resonance imaging targeted transcranial magnetic stimulation (the BRIGhTMIND trial)

Crossref DOI link: https://doi.org/10.1186/s12888-025-06893-2

Published Online: 2025-07-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Boutry, Clement

Webster, Lucy

Thomson, Louise

Harding, Delilah

Reid, Isabel

Bates, Peter

Gledhill, John

McNaughton, Rebecca

Eastham, Jane

Ooi, Joanne

Willis, Andy

Marner, Sonal

Morriss, Richard
Funding

Funding for this research was provided by:

Efficacy and Mechanism Evaluation (EME) programme

Magstim plc
License Information

Text and Data Mining valid from 2025-07-25

Version of Record valid from 2025-07-25
More Information

Article History

Received: 23 October 2024

Accepted: 21 April 2025

First Online: 25 July 2025

Declarations

:

: The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All procedures involving patients were approved by East Midlands Leicester Central Research Ethics Committee (ref: 18/EM/0232) on 30 August 2018. All participants were notified about their rights before interviewing and provided an informed consent to participate.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below